Yaozh.com, a leading domestic pharmaceutical big data service platform, has officially signed a strategic cooperation agreement with Protheragen, Inc. and its affiliates. Built on a synergistic "Data + Capital" model, the two parties will integrate Protheragen’s expertise in cross-border investment, incubation, and BD transactions with Yaozh’s strengths in pharma big data, industry resources, and project discovery. Together, the two parties will provide comprehensive support—from data insights to capital enablement—for the globalization of innovative Chinese biopharma projects.
Amid the restructuring of the global pharmaceutical supply chain and the accelerated convergence of innovation resources, cross-border synergy has become a core pathway for the globalization of Chinese biopharma innovations. This strategic partnership between Yaozh and Protheragen directly responds to this trend, creating effective alignment between domestic pharmaceutical data resources and overseas capital and BD capabilities.
Leveraging its pharmaceutical industry data resources and market analysis capabilities, Yaozh provides data-driven support for project discovery, industry research, and collaboration opportunity identification. By connecting industry intelligence with project assets, Yaozh helps innovative biopharma projects enhance decision-making efficiency and market judgment.
Protheragen Inc. focuses on cross-border biopharmaceutical investment, project incubation, and international BD collaboration, supporting overseas resource integration and business development initiatives. In this partnership, Protheragen will leverage its global industry network to support innovative pharmaceutical projects in expanding overseas partnership opportunities.
Moving forward, both parties will fully leverage their respective strengths in biopharma industry data, project pipelines, cross-border BD, and international partner networks to foster the deep integration of industry resources with the global innovation ecosystem.
Through complementary synergies and resource alignment, both parties will jointly explore new pathways for the global growth of biopharma innovations, helping innovative projects connect with international markets and accelerating exchange and collaboration between Chinese biopharma innovators and global industry resources.
This strategic partnership represents not only a convergence of complementary capabilities but also a deeper collaboration aligned with the evolving global development landscape. Guided by data insights, industry connections, and global collaboration, both parties will continuously drive value discovery and international expansion for innovative projects, co-building an open, efficient, and sustainable biopharma collaboration ecosystem.
Collaborative support for specific projects will be conducted on a case-by-case basis, subject to the actual status of the project and further mutual negotiation.
Founded in 2006, Yaozh has accumulated two decades of expertise in pharmaceutical data services and industry enablement. Yaozh.com serves 1.5 million individual members and over 50,000 corporate and government users. It has grown into a comprehensive pharmaceutical industry big data service and enablement platform centered around Yaozh Data, integrating Yaozh Consulting, Yaozh Media, and Yaozh Industry Brain. Driven by the deep integration of data, market research, and AI technology, Yaozh has established an AI company in Shanghai, developing AI-powered platforms and large language model capabilities for the biopharmaceutical industry to deliver intelligent services such as information monitoring and report generation.
Adhering to the core philosophy of " Creating Value Through Data, Serving Industry Through Platforms, Empowering Users Through Results, and Fostering Ecosystem Collaboration", Yaozh is committed to building a connected biopharmaceutical industry ecosystem. It hosts three major industry conferences annually—each with nearly 1,000 attendees—alongside dozens of industry salons to facilitate communication and progress across the biopharma sector.
Headquartered in New York, USA, Protheragen Inc. is a company deeply rooted in the global pharmaceutical and biomedical sectors. We have long been dedicated to providing biotechnology and pharmaceutical companies with comprehensive investment, incubation, and international expansion support services. We boast a dynamic and well-structured team of professionals committed to fostering and facilitating collaborative opportunities within the global pharmaceutical industry to advance the development of innovative medicine. Core to our team are biomedical Ph.D.s from top U.S. universities who leverage strategic market advantages to navigate the complexities of the pharmaceutical landscape and build bridges for cross-border collaboration.
Protheragen's business is growing rapidly after founded in New York. Our business has evolved from the initial cross-border BD consulting service to encompass segments in equity investment and project incubation.
 |
Protheragen Inc. |
 |
Quick Links |
